Steven J. Weintraub

Affiliations: 
Washington University, Saint Louis, St. Louis, MO 
Area:
Molecular Biology, Cell Biology, Oncology
Google:
"Steven Weintraub"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dho SH, Manson SR, Jung SH, et al. (2018) Bcl-x deamidation is regulated by multiple ion transporters and is intramolecularly catalyzed. Biochimica Et Biophysica Acta
Dho SH, Deverman BE, Lapid C, et al. (2013) Control of cellular Bcl-xL levels by deamidation-regulated degradation. Plos Biology. 11: e1001588
Jiang X, Austin PF, Niederhoff RA, et al. (2009) Mechanoregulation of proliferation. Molecular and Cellular Biology. 29: 5104-14
Wang J, Day R, Dong Y, et al. (2009) Abstract C167: Trop2 as a target for breast cancer treatment Molecular Cancer Therapeutics. 8
Wang J, Day R, Dong Y, et al. (2008) Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Molecular Cancer Therapeutics. 7: 280-5
Weintraub SJ, Deverman BE. (2007) Chronoregulation by asparagine deamidation. Science's Stke : Signal Transduction Knowledge Environment. 2007: re7
Henderson CC, Zhang Z, Manson SR, et al. (2005) A moderate reduction of Bcl-x(L) expression protects against tumorigenesis; however, it also increases susceptibility to tissue injury. Oncogene. 24: 7120-4
Weintraub SJ, Manson SR, Deverman BE. (2004) Resistance to antineoplastic therapy. The oncogenic tyrosine kinase-Bcl-x(L) axis. Cancer Cell. 5: 3-4
Austin PF, Niederhoff RA, Cook BL, et al. (2004) 1721: Regulation of Smooth Muscle Hyperplasia in the Obstructed Bladder by Nuclear Proteins Journal of Urology. 171: 455-455
Deverman BE, Weintraub SJ. (2004) 984: The Sodium/Hydrogen Exchanger 1 Protein in the Bladder Cancer Response to Cisplatin Treatment Journal of Urology. 171: 260-261
See more...